HCV/HIV Virtual Roundtable Webinar - 1/31/2020

Recent success treating HCV and HIV is threatened by the rise of injection drug use (IDU) and the shifting demographics of people who inject drugs (PWID). As treatments become simpler, ...

Recent success treating HCV and HIV is threatened by the rise of injection drug use (IDU) and the shifting demographics of people who inject drugs (PWID). As treatments become simpler, more effective, and more readily available, the responsibility to screen at-risk populations and manage patients to prevent and treat these dangerous infections has never been greater.

Join Kathleen Brady, MD, PhD, Alain Litwin, MD, and Sandra Springer, MD in a case based webinar to address ways that you can help fight against the surge in HCV and HIV. Topics include:
-Identifying high-risk patient populations
-Screening conversations and mitigating stigma
-IDU and transmission rates
-Managing HIV and HCV treatment
-Pre-exposure prophylactic therapy initiation (PrEP)

At the conclusion of each webinar, participants will have an opportunity to engage in a live Q&A session with our expert faculty.

Write the first review